University of Liverpool-led AGILE Study Suggests Promise of Nitazoxanide for COVID-19
The University of Liverpool in the United Kingdom led the AGILE platform master protocol known as the AGILE trial, a Phase 1 study evaluating a…
The Battle Over COVID-19 Boosters Sure Doesn’t Boost the Public’s Trust
Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Whenever I think about the public…
NYU Langone Selected as the Backbone of NIH’s $1.5b Long COVID-19 Research Program: RECOVER Initiative
NYU Langone has emerged as a pivotal academic medical center in the U.S. government’s research response to the COVID-19 pandemic. NYU Langone Health was selected…
Osaka University-led Study Indicates Potential Challenges for Pfizer-BioNTech COVID-19 Vaccine
A recent study led by Osaka University immunochemistry professor Hisashi Arase implicates the potential need to develop new COVID-19 vaccines to combat the evolving SARS-CoV-2…
FDA and International Experts Unsure About COVID-19 Booster Shots
The vaccine booster dose discussion is heating up. Contention between the vaccine manufacturers, public health officials, and federal drug regulators mounts. Driven potentially as much…